Philips and BG Medicine partner in molecular medicine for early detection and monitoring of diseases

15-Aug-2006

Philips announced that it has reached a development partnership agreement with BG medicine. Under the agreement Philips Research will collaborate with BG Medicine to advance Philips' development of patient-centered diagnostics and personalized medicine. As a further part of this strategic agreement Philips will take a minority stake in BG Medicine.

The Philips-BG Medicine partnership is an extension of Philips' existing molecular medicine research and development efforts. The collaboration gives Philips access to certain BG Medicine proprietary biomarker discovery and validation technologies, and associated services.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

See the theme worlds for related content